先天性心脏病介入治疗的新技术进展和展望

Progress and perspective of new interventional techniques in treatment of congenital heart disease

近年来先天性心脏病(CHD)的介入治疗获得了长足的进展。CHD的经导管封堵术已成为一种常规的治疗手段,但植入体内的封堵器可能对人体造成潜在的危害。旨在减少或消除体内异物残存的生物可降解封堵器可能是一种更好的选择。由于血管内支架技术的进展,经皮瓣膜置换术引起了广泛的关注,随着装置和技术的进一步改进和提高,该方法有望成为瓣膜病变的常规治疗手段。"镶嵌治疗"是CHD的一种新的治疗策略,外科医师和介入治疗医师相互协作并发挥其特长,从而为CHD提供最合适的治疗方法以获取最佳的治疗效果。这一崭新的理念将会给某些复杂CHD患者带来新的治疗选择。

The field of interventional cardiology for congenital heart disease has experienced considerable progress in the last few years.Transcatheter closure of congenital heart defect is now a well-established procedure,but potential dangers of a foreign object in the body are still concerned.Bioabsorbable device aiming at leaving little or no foreign material behind remains promising alternatives for the future.Percutaneous valve replacement has received tremendous interest as a direct result of advancement in endovascular techniques.With further development and improvement,this technique is expected to be used routinely in clinical practice.The 'hybrid' approach,a novel strategy to congenital heart disease,allows surgeons and interventional cardiologists to combine their expertise and provide the best approach to correct or palliate these defects with optimal outcomes.This concept may enable new treatment options,especially in patients with complex congenital heart defects.